Mauritius vs United Arab Emirates: Protecting minority investors: Extent of corporate transparency index
Mauritius
71.43
in 2019
United Arab Emirates
71.43
in 2019
Mauritius rank
53rd
United Arab Emirates rank
53rd
Protecting minority investors: Extent of corporate transparency index over time
- Mauritius
- United Arab Emirates
How they compare
Mauritius currently reports 71.43 against 71.43 in United Arab Emirates, a difference of 0.
Across all 7 years both countries report, United Arab Emirates has been ahead every year.
Mauritius ranks 53rd and United Arab Emirates ranks 53rd of 191 countries.
United Arab Emirates has averaged higher in every one of the 1 decades both report.
Frequently asked questions
- Which has higher protecting minority investors: extent of corporate transparency index, Mauritius or United Arab Emirates?
- Mauritius, at 71.43 against 71.43 in United Arab Emirates as of 2019.
- What is the difference in protecting minority investors: extent of corporate transparency index between Mauritius and United Arab Emirates?
- 0, with Mauritius ahead.
- How many years of comparable data are there for Mauritius and United Arab Emirates?
- 7 years are reported by both, from 2013 to 2019.
- How do Mauritius and United Arab Emirates rank globally for protecting minority investors: extent of corporate transparency index?
- Mauritius ranks 53rd and United Arab Emirates ranks 53rd of 191 countries.
- Where does this data come from?
- The World Bank, published as Protecting minority investors: Extent of corporate transparency index (0-7) (DB15-20 methodology) - Score. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
The score for extent of corporate transparency index benchmarks economies with respect to the regulatory best practice on the indicator. The score is indicated on a scale from 0 to 100, where 0 represents the worst regulatory performance and 100 the best regulatory performance, and is computed based on the methodology in the DB15-20 studies.